For citations:
Abdullaev SP, Abdullaev SP, Shatokhin MN, Krasnov AV, Bochkov PO, Tuchkova SN, Loran OB, Sychev DA. Impact of CYP2D6 polymorphisms on the pharmacokinetics, efficacy, and safety of tamsulosin therapy in patients with benign prostatic hyperplasia. Meditsinskiy sovet = Medical Council. 2024;(23):244-254. (In Russ.) https://doi.org/10.21518/ms2024-478